Harvard Intensive Review of Nephrology 2025

Overview

The Harvard Intensive Review of Nephrology 2025 offers a comprehensive clinical update and board review through a collection of over 70 interactive lectures, case discussions, and board preparation sessions. This program synthesizes state-of-the-art nephrology knowledge into practical guidance designed for clinicians aiming to stay current with diagnosis, treatment, and management of kidney diseases.

On-demand nephrology education — accessible anytime, anywhere.

Content

This program provides an extensive review of major nephrology topics, emphasizing clinical application and evidence-based strategies:

• Glomerulonephritis: Basic pathology, urinary sediment interpretation, and latest treatment guidelines for rapidly progressive glomerulonephritis, lupus nephritis, IgA nephropathy, membranous nephropathy, minimal change disease, and C3 glomerulonephritis.
• Chronic Kidney Disease (CKD): Epidemiology, management best practices, diabetic kidney disease care, geriatric nephrology, and novel drug therapies.
• Genetic Kidney Disease: State-of-the-art approaches, renal panel genetic testing, and updates on polycystic kidney disease.
• Acute Kidney Injury (AKI): Diagnostic workup, biomarker utilization, renal replacement therapy guidelines in ICU settings, thrombotic microangiopathies, and cardiorenal and hepatorenal syndromes.
• Vascular Disease: Hypertension diagnosis and management, renovascular disease approaches.
• Electrolytes and Acid-Base: Interpretation and management fundamentals for electrolyte disorders and acid-base cases.
• End-Stage Renal Disease: Updates on hemodialysis, peritoneal dialysis, vascular access, anemia management, and mineral and bone disorder treatment.
• Transplantation: Tissue typing interpretation, immunosuppressive therapy guidelines, allograft rejection management, donor and recipient evaluation, and infection treatment post-transplant.
• Tailoring Treatment for Special Populations: Cancer-related kidney disease, pregnancy and renal disease, pediatric nephrology perspectives for adult practitioners, mesoamerican nephropathy, diabetic kidney disease pathophysiology and treatment, and addressing racial disparities.

Key highlights include genetic testing advancements, point-of-care ultrasound fundamentals, dialysis access physical examination, expanded roles of SGLT2 inhibitors and finerenone, immunology insights in glomerulonephritis, and novel immunosuppressive agents.

Speakers

This program is presented by clinical faculty affiliated with Harvard Medical School, featuring experts in nephrology who provide evidence-based, clinically relevant education. Specific speaker details are not provided.

Target Audience

This course is designed for nephrologists, clinicians, nurse practitioners, and physician assistants seeking comprehensive, up-to-date knowledge across nephrology subspecialties to support clinical decision-making and patient management.

Why This Topic Matters

The Harvard Intensive Review of Nephrology 2025 addresses critical updates in nephrology, supporting healthcare professionals in enhancing their expertise in this specialized field. Staying informed on current diagnostic and therapeutic strategies is essential for effective patient care in nephrology.

MedHub Central provides access to this thorough nephrology resource, enabling clinicians to reinforce their knowledge and apply best practices confidently in clinical settings.